The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Will The Market Size Of The GMP Cell Therapy Consumables Market Progress Through 2030?
The gmp cell therapy consumables market size has experienced exponential growth in recent years. It is anticipated to expand from $22.73 billion in 2025 to $28.79 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 26.7%. This historic growth can be attributed to the broadening of clinical cell therapy trials, the development of regenerative medicine research, the increasing adoption of gmp manufacturing standards, rising investments in cell-based therapies, and the availability of advanced cell culture tools.
The gmp cell therapy consumables market size is projected to experience substantial growth in the coming years, reaching $73.96 billion by 2030 with a compound annual growth rate (CAGR) of 26.6%. This expansion during the forecast period is attributed to factors like the increasing commercialization of cell therapies, a rising demand for scalable gmp production, the broadening of gene and immunotherapy pipelines, a growing emphasis on process automation, and increasing regulatory scrutiny of cell therapy manufacturing. Major trends anticipated for this period include a heightened demand for gmp-compliant cell therapy consumables, the rising adoption of single-use bioprocessing products, the growing implementation of automated cell processing systems, the expansion of standardized cell culture solutions, and an enhanced focus on quality and regulatory compliance.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12014&type=smp
Which Significant Factors Are Encouraging Growth In The GMP Cell Therapy Consumables Market?
The increasing occurrence of chronic diseases is anticipated to propel the expansion of the GMP cell therapy consumables market in the future. A chronic disease is defined as an ailment that persists for three months or more and has the potential to deteriorate over time. The rise in chronic diseases leads to intensified research and development efforts in innovative cell therapies to manage these conditions. As cell therapy applications expand to cover various chronic diseases, the demand for GMP consumables increases, requiring careful quality assurance in clinical trials. Additionally, stringent regulatory adherence and patient expectations for cutting-edge therapies further contribute to the market’s growth. For example, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, representing an 18% increase from 3,065,825 cases in 2022. Consequently, the growing prevalence of chronic diseases is a key factor driving the growth of the GMP cell therapy consumables market.
How Are Different Segment Groups Identified Within The GMP Cell Therapy Consumables Market?
The gmp cell therapy consumables market covered in this report is segmented –
1) By Product: Kits, Reagents Or Molecular Biology Reagents, Growth Factors Or Cytokines And Interleukins, Other Products
2) By Cell Therapy: NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy
3) By Process: Cell Collection And Characterization Or Sorting And Separation, Cell Culture And Expansion Or Preparation, Cryopreservation, Cell Processing And Formulation, Cell Isolation And Activation
4) By End-Use: Clinical, Commercial
Subsegments:
1) By Kits: Cell Culture Kits, Cell Isolation Kits, Transfection Kits
2) By Reagents Or Molecular Biology Reagents: Buffers And Solutions, Enzymes, Staining Reagents
3) By Growth Factors Or Cytokines And Interleukins: Hematopoietic Growth Factors, Immunomodulatory Cytokines
4) By Other Products: Cell Culture Vessels, Media And Supplements
Which Trends Are Guiding The Development Of The GMP Cell Therapy Consumables Market?
Major companies within the GMP cell therapy consumables market are engaged in the development of GMP-compliant CD34+ hematopoietic stem cells (HSCs) to support advanced therapies. These GMP-compliant CD34+ hematopoietic stem cells (HSCs) are defined as a specific type of stem cell that displays the CD34 marker on its surface and is manufactured under Good Manufacturing Practice (GMP) conditions. For example, in April 2024, OrganaBio, a pharmaceutical company based in the US, introduced HematoPAC-HSC-CB-GMP, an on-demand source of GMP-compliant CD34+ hematopoietic stem cells (HSCs) sourced from fresh human cord blood. OrganaBio leverages its considerable experience in cell isolation and GMP manufacturing processes to yield high quantities of highly viable CD34+ HSCs within 24 hours of collection. This recent launch seeks to advance the creation of next-generation therapies, including treatments for blood cancers and genetic disorders.
Who Are The Key Market Participants In The GMP Cell Therapy Consumables Market?
Major companies operating in the gmp cell therapy consumables market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, Sartorius AG, Corning Incorporated, Avantor Inc., Fresenius Kabi AG, Miltenyi Biotec, Bio-Techne Corp, STEMCELL Technologies Inc., FUJIFILM Irvine Scientific Inc., BioLife Solutions Inc., PromoCell GmbH, PeproTech Inc., Sino Biological Inc., Wilson Wolf Corporation, Cellexus Ltd., MaxCyte Inc., BioLegend Inc., Repligen Corporation, Terumo Corporation
Access The Complete GMP Cell Therapy Consumables Market Report:
https://www.thebusinessresearchcompany.com/report/gmp-cell-therapy-consumables-global-market-report
Which Region Is The Dominant Market In The GMP Cell Therapy Consumables Market?
North America was the largest region in the GMP cell therapy consumables market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gmp cell therapy consumables market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a GMP Cell Therapy Consumables Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/report/gmp-cell-therapy-consumables-global-market-report
Browse Through More Reports Similar to the Global GMP Cell Therapy Consumables Market 2026, By The Business Research Company
Cell Therapy Technologies Market Report 2026
https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report
Cell And Gene Therapy Manufacturing Services Market 2026
Cell And Gene Therapy Clinical Trial Services Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model